Veer Bhavnagri - Net Worth and Insider Trading

Veer Bhavnagri Net Worth

The estimated net worth of Veer Bhavnagri is at least $2 Million dollars as of 2024-11-13. Veer Bhavnagri is the General Counsel of Allogene Therapeutics Inc and owns about 577,677 shares of Allogene Therapeutics Inc (ALLO) stock worth over $2 Million. Details can be seen in Veer Bhavnagri's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Veer Bhavnagri has not made any transactions after 2023-02-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Veer Bhavnagri

To

Veer Bhavnagri Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Veer Bhavnagri owns 1 companies in total, including Allogene Therapeutics Inc (ALLO) .

Click here to see the complete history of Veer Bhavnagri’s form 4 insider trades.

Insider Ownership Summary of Veer Bhavnagri

Ticker Comapny Transaction Date Type of Owner
ALLO Allogene Therapeutics Inc 2023-02-13 General Counsel

Veer Bhavnagri Latest Holdings Summary

Veer Bhavnagri currently owns a total of 1 stock. Veer Bhavnagri owns 577,677 shares of Allogene Therapeutics Inc (ALLO) as of February 13, 2023, with a value of $2 Million.

Latest Holdings of Veer Bhavnagri

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALLO Allogene Therapeutics Inc 2023-02-13 577,677 2.84 1,640,603

Holding Weightings of Veer Bhavnagri


Veer Bhavnagri Form 4 Trading Tracker

According to the SEC Form 4 filings, Veer Bhavnagri has made a total of 14 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 3,000 shares on February 13, 2023, which brought Veer Bhavnagri around $20,550.

Insider Trading History of Veer Bhavnagri

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Veer Bhavnagri Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Veer Bhavnagri Ownership Network

Ownership Network List of Veer Bhavnagri

No Data

Ownership Network Relation of Veer Bhavnagri

Insider Network Chart

Veer Bhavnagri Owned Company Details

What does Allogene Therapeutics Inc do?

Who are the key executives at Allogene Therapeutics Inc?

Veer Bhavnagri is the General Counsel of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & 10 percent owner Arie Belldegrun , CHIEF FINANCIAL OFFICER Geoffrey M. Parker , and GENERAL COUNSEL Earl Martin Douglas .

Allogene Therapeutics Inc (ALLO) Insider Trades Summary

Over the past 18 months, Veer Bhavnagri made no insider transaction in Allogene Therapeutics Inc (ALLO). Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 37,281 shares made by Deborah M. Messemer , a net purchase of 1,724,137 shares made by Arie Belldegrun , and a net sale of 11,200 shares made by Franz B Humer .

In summary, during the past 3 months, insiders sold 0 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,481 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,665,846 shares.

Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Allogene Therapeutics Inc Insider Transactions

No Available Data

Veer Bhavnagri Mailing Address

Above is the net worth, insider trading, and ownership report for Veer Bhavnagri. You might contact Veer Bhavnagri via mailing address: C/o Allogene Therapeutics, Inc., 210 E. Grand Avenue, South San Francisco Ca 94080.